Highbridge Capital Management LLC Has $34.60 Million Stock Holdings in Amedisys, Inc. (NASDAQ:AMED)

Highbridge Capital Management LLC boosted its holdings in shares of Amedisys, Inc. (NASDAQ:AMED - Free Report) by 18.0% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 381,123 shares of the health services provider's stock after buying an additional 58,223 shares during the period. Amedisys makes up about 1.3% of Highbridge Capital Management LLC's holdings, making the stock its 27th biggest position. Highbridge Capital Management LLC owned approximately 1.16% of Amedisys worth $34,602,000 at the end of the most recent quarter.

Other hedge funds have also recently bought and sold shares of the company. Blue Trust Inc. increased its stake in shares of Amedisys by 55.1% in the fourth quarter. Blue Trust Inc. now owns 349 shares of the health services provider's stock worth $34,000 after acquiring an additional 124 shares during the last quarter. HBW Advisory Services LLC bought a new position in shares of Amedisys in the fourth quarter worth about $38,000. Versant Capital Management Inc lifted its position in shares of Amedisys by 68.5% during the 4th quarter. Versant Capital Management Inc now owns 450 shares of the health services provider's stock worth $41,000 after purchasing an additional 183 shares during the last quarter. Vestcor Inc acquired a new position in shares of Amedisys during the 4th quarter worth about $73,000. Finally, Venturi Wealth Management LLC boosted its stake in Amedisys by 397.4% during the 4th quarter. Venturi Wealth Management LLC now owns 975 shares of the health services provider's stock valued at $89,000 after purchasing an additional 779 shares during the period. 94.36% of the stock is owned by hedge funds and other institutional investors.

Remove Ads

Amedisys Stock Performance

AMED stock traded down $0.10 during midday trading on Tuesday, hitting $92.53. The stock had a trading volume of 57,028 shares, compared to its average volume of 394,095. Amedisys, Inc. has a 52 week low of $82.15 and a 52 week high of $98.95. The company has a current ratio of 1.19, a quick ratio of 1.19 and a debt-to-equity ratio of 0.05. The stock has a 50-day simple moving average of $92.29 and a 200 day simple moving average of $92.37. The firm has a market capitalization of $3.04 billion, a price-to-earnings ratio of 36.70, a P/E/G ratio of 1.78 and a beta of 0.76.

Amedisys (NASDAQ:AMED - Get Free Report) last posted its earnings results on Wednesday, February 26th. The health services provider reported $0.96 earnings per share for the quarter, missing the consensus estimate of $1.05 by ($0.09). Amedisys had a return on equity of 12.20% and a net margin of 3.57%. The firm had revenue of $598.05 million during the quarter, compared to the consensus estimate of $602.38 million. As a group, equities research analysts anticipate that Amedisys, Inc. will post 4.4 earnings per share for the current year.

Analyst Ratings Changes

Separately, Stephens reaffirmed an "equal weight" rating and issued a $101.00 price target on shares of Amedisys in a research report on Tuesday, March 4th. Four analysts have rated the stock with a hold rating and one has assigned a buy rating to the company's stock. According to MarketBeat, the company currently has a consensus rating of "Hold" and a consensus price target of $101.00.

Amedisys Profile

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.